MHRA Warns of Botulism Risk Following Botulinum Toxin Use
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued a safety alert regarding the risk of iatrogenic botulism—a rare but serious condition—following the administration of botulinum toxin for ... Read More